Suppr超能文献

大鼠中枢α1和α2肾上腺素能受体对交感神经张力的相互作用

Interaction between central alpha 1- and alpha 2-adrenoceptors on sympathetic tone in rats.

作者信息

Huchet A M, Huguet F, Tsoucaris-Kupfer D, Legrand M, Narcisse G

出版信息

Neuropharmacology. 1986 May;25(5):509-14. doi: 10.1016/0028-3908(86)90176-0.

Abstract

The interaction between piperoxan and alpha 2-agonists on sympathetic tone was studied in rats. The sympatho-inhibitory effect of alpha 2-agonists (clonidine, guanfacine, B-HT 933) was assessed by recording heart rate in normotensive bilaterally-vagotomized rats. Clonidine (3 micrograms/kg, i.c.v.) and B-HT 933 (100 micrograms/kg, i.c.v.) induced a bradycardia which was fully reversed by piperoxan (30 micrograms/kg, i.c.v.). However, in rats treated with guanfacine, piperoxan induced a partial recovery of the bradycardic effect. The injection of a small dose of the specific alpha 1-adrenoceptor blocking drug, AR-C 239 (10 micrograms/kg, i.c.v.) which, by itself did not modify heart rate, completely inhibited the reversal effect of piperoxan in rats treated with clonidine, B-HT 933 or guanfacine. In rat brainstem membranes, B-HT 933 was found to bind to both alpha 1- and alpha 2-adrenoceptors and was as potent as clonidine in competing for alpha 1-sites bound by [3H]prazosin. On the other hand, in bilaterally vagotomized rats, piperoxan (30 micrograms/kg, i.c.v.) induced an increase in blood pressure and heart rate which was inhibited by previous administration of AR-C 239 (10 micrograms/kg, i.c.v.). These data suggest that, by inhibiting central alpha 2-adrenoceptors, piperoxan unmasks central alpha 1-adrenoceptor stimulation by endogenous catecholamines leading to an increase in the sympathetic tone, but a full recovery in heart rate could be observed only with the mixed alpha 1- and alpha 2-adrenoceptor agonists, clonidine and B-HT 933. In addition, these data further indicate that alpha 1-adrenoceptors are implicated in a tonic control of the sympathetic nerve activity in normotensive rats.

摘要

在大鼠中研究了哌罗克生和α2-激动剂对交感神经张力的相互作用。通过记录正常血压双侧迷走神经切断大鼠的心率来评估α2-激动剂(可乐定、胍法辛、B-HT 933)的交感抑制作用。可乐定(3微克/千克,脑室内注射)和B-HT 933(100微克/千克,脑室内注射)诱导心动过缓,哌罗克生(30微克/千克,脑室内注射)可使其完全逆转。然而,在用胍法辛治疗的大鼠中,哌罗克生可使心动过缓效应部分恢复。注射小剂量的特异性α1-肾上腺素能受体阻断药物AR-C 239(10微克/千克,脑室内注射),其本身不改变心率,但能完全抑制哌罗克生对用可乐定、B-HT 933或胍法辛治疗的大鼠的逆转作用。在大鼠脑干膜中,发现B-HT 933与α1-和α2-肾上腺素能受体均有结合,并且在竞争[3H]哌唑嗪结合的α1位点方面与可乐定一样有效。另一方面,在双侧迷走神经切断的大鼠中,哌罗克生(30微克/千克,脑室内注射)可诱导血压和心率升高,而预先给予AR-C 239(10微克/千克,脑室内注射)可抑制这种升高。这些数据表明,通过抑制中枢α2-肾上腺素能受体,哌罗克生可暴露内源性儿茶酚胺对中枢α1-肾上腺素能受体的刺激,导致交感神经张力增加,但仅在α1-和α2-肾上腺素能受体混合激动剂可乐定和B-HT 933作用下才能观察到心率完全恢复。此外,这些数据进一步表明α1-肾上腺素能受体参与正常血压大鼠交感神经活动的紧张性控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验